For Mothers

iGene Sticker 7.png

What is iGene® NIPT

iGene® NIPT is a non-invasive prenatal screening test that analyses cell-free fetal DNA (cffDNA) present in maternal blood. This DNA comes from the placenta and circulates freely in the maternal bloodstream.

 

iGene® NIPT screens for Trisomy 21 (Down Syndrome), Trisomy 18 (Edward Syndrome), Trisomy 13 (Patau Syndrome), Sex Chromosome Aneuploidies and selected Deletions[1].  

iGene® NIPT is powered by BGI Technology

Medical treatment has to be individualised and can only be rendered after adequate assessment of your condition through appropriate clinical examination, and after discussion with your doctor. You should not rely on the information provided herein. Please note that the contents of this page are provided on the understanding that no surgical or medical advice or recommendation is being rendered. Please refer to our website Terms of Use.

iGene® NIPT is simple

iGene® NIPT is performed using a simple blood draw from 10 weeks of pregnancy.

iGene® NIPT is non-invasive

iGene® NIPT detects cell-free fetal DNA (cffDNA) from as little as 10ml of maternal blood.

iGene® NIPT can detect

 T21, T18 and T13

iGene® NIPT detects Down Syndrome (T21), Edward Syndrome (T18) and Patau Syndrome (T13)[1].

iGene® NIPT is powered by BGI Technology

Whole Genome Sequencing

Technology

Using Whole Genome Sequencing technology, iGene® NIPT is non-invasive and detects Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome)[1].

*All images are for illustration purposes only.

iGene® NIPT is powered by BGI Technology

How does iGene® NIPT work

1

Discuss with

your Clinician

The American College of Medical Genetics and Genomics (ACMG) recommends informing pregnant women that NIPT is an option to screen for Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome)[2]. Please discuss with your clinician for further information.

2

Fill in the Form

You may order the iGene® NIPT test at your doctor's clinic from 10 weeks of pregnancy. iGene® NIPT requires a minimum of 10 ml of the maternal blood sample. Your doctor will provide you with an iGene® NIPT Request & Consent Form, which needs to be signed by you and your doctor.

3

Get Your Results

After approximately 7 to 10 working days, the report is sent to your doctor. Your doctor will discuss the results with you.

 

If your result is “Screen Negative”, it suggests a low risk for the tested trisomies.

 

If your result is “Screen Positive”, please discuss with your clinician further.

iGene® NIPT is powered by BGI Technology

Frequently Asked Questions (FAQs)

References:

1. Zhang H, et al. (2015) Ultrasound Obstet. & Gynecol. 10.1002/uog/14792.

2. Gregg, A. R., et al. (2016). Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine. doi:10.1038/gim.2016.97

 

iGene® NIPT is powered by BGI Technology

iGene® NIPT is tested at iGene Laboratory Pte Ltd, a wholly owned subsidiary of INEX Innovate Private Limited,

iGene Laboratory is licensed by the Ministry of Health of Singapore as a Clinical Laboratory

(License Number: 17I0382/02/192) to provide services in Molecular Pathology (Non-Invasive Prenatal Testing).

  • Facebook
  • Instagram
© 2020 iGene Laboratory Pte Ltd
Last updated: Feb 2020